Project Grant R16GM160795
- This federal Project Grant award of $151,040.00 was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) to The Regents of the University of California, doing business as the University of California, Berkeley. The funding supports research to develop supramolecular photocatalysts that can enable novel photochemical reactions to produce oxygen- and nitrogen-containing heterocycles in a highly selective...
- This federal Project Grant award for $460,413.00, provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), aims to develop a novel visible light-induced transition metal-radical hybrid catalytic methodology for regiocontrolled, mild, and exogenous oxidant-free functionalizations of saturated groups. The proposed research seeks to create a platform for controlled, selective functionalization of organic...
- This federal Project Grant award of $386,617 from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) aims to develop safer and more efficient chemical methods for the synthesis of complex, fluorinated, and highly functional pharmaceutical compounds. The key research areas encompass: (1) electromicellar catalysis for the formation of fluorinated heterocycles, allenes, and reactive intermediates; (2) enantioselective...
- This federal Project Grant award, provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), is funding research on enantioselective chemical synthesis methods using Lewis base and transition metal catalysis. The $631,989 award to the Trustees of Indiana University, awarded on September 5, 2025, aims to develop a general, modular, and operationally trivial toolbox of effective stereoselective reactions by...
- This $244,450 Project Grant, awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), supports research to understand the catalytic mechanisms, structural dynamics, and biomedical importance of two key classes of metalloenzymes: matrix metalloproteinases (MMPs) and iron(II)/2-oxoglutarate (2OG)-dependent oxygenases. The project, spanning July 2025 to June 2030, aims to provide missing knowledge on these...
- This federal Project Grant award of $524,400.00 was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The funding supports research at the Scripps Research Institute in La Jolla, CA to develop novel chemical transformations and catalysts that enable the efficient synthesis of structurally complex small molecules for drug discovery. The research aims to address challenges in organic synthesis by...
- This federal Project Grant award of $620,000 from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) supports a research project at Boston College focused on "Catalytic Radical Processes for Stereoselective Chemical Synthesis." The research aims to establish metalloradical catalysis as a framework for controlling the reactivity and stereoselectivity of homolytic radical reactions in organic synthesis. The...
- The University of California, Merced received a $550,108 Project Grant award under the National Institute of General Medical Sciences' (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) to conduct fundamental research on the genetic regulation of microbial community formation, with a focus on biofilms. The project, which runs from May 5, 2025 to March 31, 2030, aims to provide new insights into the molecular and mechanistic bases of biofilm development, regulation, and...
- The National Institute of General Medical Sciences (NIGMS) awarded Brigham Young University a $439,203 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to support a research project titled "Using Catalyst Speciation to Control Reactivity and Address Longstanding Challenges in Cross Coupling Reactions." The project aims to develop new catalyst ligands based on 2-phosphinoimidazole (2-PI) compounds that can enable efficient catalysis for challenging...
- Regents of the University of California at Riverside was awarded $540,000 under a three-year Project Grant from the National Science Foundation's Mathematical and Physical Sciences program (CFDA 47.049). The grant will support research into developing new biomimetic chemical structures that can mimic the behavior of large biomolecules like enzymes. Specifically, Professor Richard Hooley and his team will work to create self-assembled cage complexes containing rigidly or flexibly positioned...
This federal Project Grant award, provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), is funding research to develop novel metal complexes based on abundant first-row metalate species for use as catalysts in biomedical and chemical applications. The $147,025 award to the University of California, Merced will support research efforts in two key areas: 1) Investigating the structural and electronic features of a new class of metal complexes in low oxidation states with N-heterocyclic phosphenium ion (NHP) support, and 2) Developing metalate-catalyzed transformations, with a focus on the functionalization of small molecules, through careful mechanistic analysis. This research aims to provide environmentally-friendly and sustainable catalytic methods that can conserve the use of precious metals, which are critical for drug development and biomedical research.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $147.0k | 8/4/25 |